Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-331373
Filing Date
2013-08-13
Accepted
2013-08-12 20:36:15
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d550964d10q.htm 10-Q 373029
2 EX-10.1 d550964dex101.htm EX-10.1 119151
3 EX-31.1 d550964dex311.htm EX-31.1 7023
4 EX-31.2 d550964dex312.htm EX-31.2 6745
5 EX-32.1 d550964dex321.htm EX-32.1 7821
  Complete submission text file 0001193125-13-331373.txt   5489861

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT srne-20130630.xml EX-101.INS 285580
7 XBRL TAXONOMY EXTENSION SCHEMA srne-20130630.xsd EX-101.SCH 32299
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srne-20130630_cal.xml EX-101.CAL 34781
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srne-20130630_def.xml EX-101.DEF 110408
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE srne-20130630_lab.xml EX-101.LAB 257148
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srne-20130630_pre.xml EX-101.PRE 179881
Mailing Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121
Business Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

EIN.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52228 | Film No.: 131031098
SIC: 8731 Services-Commercial Physical & Biological Research